Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.

作者: Ying Li , Ziwei Liao , Huacheng Luo , Aissa Benyoucef , Yuanyuan Kang

DOI: 10.1093/NAR/GKAA098

关键词:

摘要: Aberrant activation of the TAL1 is associated with up to 60% T-ALL cases and involved in CTCF-mediated genome organization within locus, suggesting that CTCF boundary plays a pathogenic role T-ALL. Here, we show -31-Kb binding site (-31CBS) serves as chromatin defines topologically associating domain (TAD) enhancer/promoter interaction required for activation. Deleted or inverted -31CBS impairs expression context-dependent manner. Deletion reduces accessibility blocks long-range between +51 erythroid enhancer promoter-1 leading inhibition cells, but not cells. However, TAL1-expressing leukemia-prone promoter-IV specifically interacts +19 stem cell located 19 Kb downstream this disrupted by inversion Inversion Jurkat cells alters accessibility, histone modifications TAD TAL1-driven leukemogenesis. Thus, our data reveal acts critical regulator define +19-enhancer leukemic prone promoter IV Manipulation can alter oncogenic transcription networks

参考文章(68)
Barin C, Bernard O, Charrin C, Berger R, Mathieu-Mahul D, Characterization of translocation t(1;14)(p32;q11) in a T and in a B acute leukemia. Leukemia. ,vol. 7, pp. 1509- 1513 ,(1993)
F. Facchiano, M. Valtieri, V. Lulli, C. Peschle, L. Vitelli, E. Proietti, G. L. Condorelli, K. Huebner, C. M. Croce, T-Cell-directed TAL-1 Expression Induces T-Cell Malignancies in Transgenic Mice Cancer Research. ,vol. 56, pp. 5113- 5119 ,(1996)
L. Robb, N. J. Elwood, A. G. Elefanty, F. Köntgen, R. Li, L. D. Barnett, C. G. Begley, The scl gene product is required for the generation of all hematopoietic lineages in the adult mouse. The EMBO Journal. ,vol. 15, pp. 4123- 4129 ,(1996) , 10.1002/J.1460-2075.1996.TB00787.X
M. A. Kelliher, D. C. Seldin, P. Leder, Tal‐1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. The EMBO Journal. ,vol. 15, pp. 5160- 5166 ,(1996) , 10.1002/J.1460-2075.1996.TB00900.X
AJ Carroll, WM Crist, MP Link, MD Amylon, DJ Pullen, AH Ragab, GR Buchanan, RS Wimmer, TJ Vietti, The t(1;14)(p34;q11) is nonrandom and restricted to T-cell acute lymphoblastic leukemia: A Pediatric Oncology Group study Blood. ,vol. 76, pp. 1220- 1224 ,(1990) , 10.1182/BLOOD.V76.6.1220.1220
L. Brown, J. T. Cheng, Q. Chen, M. J. Siciliano, W. Crist, G. Buchanan, R. Baer, Site-specific recombination of the tal-1 gene is a common occurrence in human T cell leukemia. The EMBO Journal. ,vol. 9, pp. 3343- 3351 ,(1990) , 10.1002/J.1460-2075.1990.TB07535.X
Carmen G Palii, Carolina Perez-Iratxeta, Zizhen Yao, Yi Cao, Fengtao Dai, Jerry Davison, Harold Atkins, David Allan, F Jeffrey Dilworth, Robert Gentleman, Stephen J Tapscott, Marjorie Brand, Differential genomic targeting of the transcription factor TAL1 in alternate haematopoietic lineages The EMBO Journal. ,vol. 30, pp. 494- 509 ,(2011) , 10.1038/EMBOJ.2010.342
Max M. van Noesel, Martine van Grotel, Jules P. P. Meijerink, Elisabeth R. van Wering, Anton W. Langerak, H. Berna Beverloo, Martin Horstmann, Rob Pieters, Pauline Schneider, Tim S. Poulsen, Willem A. Kamps, Jessica G. C. A. M. Buys-Gladdines, Anjo J. P. Veerman, Monique L. den Boer, The outcome of molecular-cytogenetic subgroups in pediatric T-cell acute lymphoblastic leukemia: a retrospective study of patients treated according to DCOG or COALL protocols. Haematologica. ,vol. 91, pp. 1212- 1221 ,(2006) , 10.3324/%X
Elzo de Wit, Erica SM Vos, Sjoerd JB Holwerda, Christian Valdes-Quezada, Marjon JAM Verstegen, Hans Teunissen, Erik Splinter, Patrick J Wijchers, Peter HL Krijger, Wouter de Laat, None, CTCF Binding Polarity Determines Chromatin Looping Molecular Cell. ,vol. 60, pp. 676- 684 ,(2015) , 10.1016/J.MOLCEL.2015.09.023